Urinary levels of tissue kallikrein in the South African Black and Indian hypertensives

Journal of Human Hypertension

Volumn 13, Issue 11, 1999, Pages 771-775

  Seedat, Y K ^a,b   Bhoola, K D ^a   Muller, R ^a   Randeree, I G H ^a   Pillay, D ^a  

^a UNIVERSITY OF KWAZULU NATAL   (South Africa)

^b UNIVERSITY OF NATAL   (South Africa)

Author keywords

Black; Hypertension; Indian; Urinary tissue kallikrein

Indexed keywords

ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; THIAZIDE DIURETIC AGENT; TISSUE KALLIKREIN;

ADULT; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; ETHNIC DIFFERENCE; FEMALE; HUMAN; HYPERTENSION; INDIAN; MALE; NEGRO; SOUTH AFRICA; STATISTICAL ANALYSIS; URINARY EXCRETION; URINE LEVEL;

EID: 0032756381     PISSN: 09509240     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jhh.1000907     Document Type: Conference Paper

References (28)

1. Bhoola KD, Figueroa CD, Worthy K. Bioregulation of kinins: kallikreins, kininogens and kininases. Pharmacol Rev 1992; 44: 1-80.
2. Clements JA. The human kallikrein gene family: a diversity of expression and function. Moll Cell Endocrinol 1994; 99: C1-C6.
3. Raidoo DM, Ramsaroop R, Naidoo S, Bhoola KD. Regional distribution of tissue kallikrein in the human brain. Immunopharmacology 1996; 32: 39-47.
4. Naidoo S, Ramsaroop R, Bhoola R, Bhoola KD. The evaluation of tissue kallikrein in Helicobacter pylori-associated gastric ulcer disease. Immunopharmacology 1997; 36: 263-269.
5. Mandle R, Jr, Kaplan AP. Hageman factor substrates II. Human plasma prekallikrein. Mechanism of activation by Hageman factor and participation in Hageman factor dependent fibrinolysis. J Biol Chem 1977; 252: 6097-6104.
6. Jacobsen S. Separation of 2 different substrates for plasma kinin forming enzymes. Nature 1966; 210: 98-99.
7. Muller-Esterl W. Kininogens, kinin and kinships. Thromb Haemost 1989; 61: 2-6.
8. Bhoola KD. Translocation of the neutrophil kinin moiety and changes in the regulation kinin receptors in inflammation. Immunopharmacology 1996; 33: 247-256.
9. Regoli D, Barabe J. Pharmacology of bradykinin and related kinins. Pharmacol Rev 1980; 32: 1-46.
10. Regoli D, Jukic D, Gobeil F, Rhaleb NE Receptors for bradykinin and related kinins: a critical analysis. Can J Physiol Pharm 1993; 71: 556-567.
11. Hess JF et al. Cloning and pharmacological characterisation of a human bradykinin (BK2) receptor. Biochem Biophys Res Co 1992; 184: 260-268.
12. 1 receptors. Immunopharmacology 1996; 33: 1-8.
13. Raidoo DM, Bhoola KD. Kinin receptors on human neurons. J Neuroimmunol 1997; 77: 39-44.
14. Figueroa CD, MacIver AG, Mackenzie JC, Bhoola KD. Localisation of immunoreactive kininogen and tissue kallikrein in the human nephron. Histochemistry 1988; 89: 437-442.
15. Lauar N, Bhoola KD. Release of tissue kallikrein from the isolated perfused kidney. Adv Exp Med Biol 1986; 198A: 347-354.
16. Chao J, Chao L. A major difference of kallikrein-binding protein in spontaneously hypertensive versus normotensive rats. J Hypertens 1988; 6: 551-557.
17. Elliot ET, Nuzum FR. Urinary excretion of a depressor substance (kallikrein of Frey and Kraut) in arterial hypertension. Endocrinology 1934; 18: 462-474.
18. Seedat YK. Varying responses to hypotensive agents in different racial groups: black versus white differences. J Hypertens 1989; 7: 515-518.
19. Warren SE, O'Connor DT. Does a renal vasodilator system mediate racial differences in essential hypertension? Am J Med 1980; 69: 425-429.
20. Dessi-Fulgheri P et al. Urinary kallikrein excretion and blood pressure response to angiotensin converting enzyme inhibitors and calcium antagonists in hypertensive patients. J Hypertens 1993; 11: 725-730.
21. Oliveros-Palacios MC, Godoy-Godoy N, Colina-Chourio JA. Effects of doxazosin on blood pressure, renin-angiotensin-aldosterone and urinary kallikrein. Am J Cardiol 1991; 67: 157-161.
22. Bellini C et al. The influence of salt sensitivity on the blood pressure response to exogenous kallikrein in essential hypertensive patients. Nephron 1993; 65: 28-35.
23. Amundsen E et al. Methods for the determination of glandular kallikrein by means of a chromogenic tripe-tide substrate. Adv Exp Med Biol 1979; 120A: 83-95.
24. Rahman MM et al. Inhibitor regulation of tissue kallikrein activity in the synovial fluid of patients with rheumatoid arthritis. Br J Rheumatol 1994; 33: 215-223.
25. Tsai TJ et al. Effects of sodium depletion on urinary excretion of active and inactive kallikrein in glomerulonephritis patients. J Formosan Med Assoc 1991; 90: 105-108.
26. Vio CP, Figueroa CD. Evidence for a stimulatory effect of high potassium diet on renal kallikrein. Kidney Int 1987; 31: 1327-1334.
27. Williams RR et al. Genetic basis of familial dyslipidemia and hypertension: 15-year results from Utah. Am J Hypertens 1993; 6: 319S-327S.
28. Koolen MI et al. Direct and indirect measurement of urinary kallikrein excretion in patients with essential hypertension and normotensives: relation to age and plasma renin and aldosterone levels. Eur J Clin Invest 1984; 14: 171-174.